Bleeding complications in women undergoing glycoprotein IIb/IIIa receptor inhibition in elective percutaneous coronary intervention: A report from the American College of Cardiology National Cardiovascular Data Registry

被引：0

作者：

Naik, HS ^{[1
]}

Yee, RR ^{[1
]}

Shaw, RE ^{[1
]}

Hui, PY ^{[1
]}

Gray, R ^{[1
]}

机构：

[1] Joint Cardiac Program CPMC, San Francisco, CA USA

来源：

CIRCULATION | 2004年 / 109卷 / 20期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

P203

引用

页码：E270 / E271

页数：2

共 50 条

[1] The risk of bleeding in renal failure patients undergoing glycoprotein IIb/IIIa receptor inhibition: A report from the American College of Cardiology-National Cardiovascular Data Registry
Naik, HS
Hui, PYM
Yee, RR
Shaw, RE
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 30A - 30A
[2] Impact of Glycoprotein IIb/IIIa Inhibition in Contemporary Percutaneous Coronary Intervention for Acute Coronary Syndromes Insights From the National Cardiovascular Data Registry
Safley, David M.
Venkitachalam, Lakshmi
Kennedy, Kevin F.
Cohen, David J.
JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (12) : 1574 - 1582
[3] The relationship of coronary sterling and glycoprotein IIb/IIIa inhibitors to PCI outcomes in insulin dependent diabetics: A report from the American College of Cardiology-National Cardiovascular Data Registry
Klein, LW
Brindis, R
Krone, R
Weintraub, W
Shaw, RE
CIRCULATION, 2002, 106 (19) : 716 - 716
[4] BLEEDING COMPLICATIONS WITH THE CHIMERIC ANTIBODY TO PLATELET GLYCOPROTEIN IIB/IIIA INTEGRIN IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION
AGUIRRE, FV
TOPOL, EJ
FERGUSON, JJ
ANDERSON, K
BLANKENSHIP, JC
HEUSER, RR
SIGMON, K
TAYLOR, M
GOTTLIEB, R
HANOVICH, G
ROSENBERG, M
DONOHUE, TJ
WEISMAN, HF
CALIFF, RM
CIRCULATION, 1995, 91 (12) : 2882 - 2890
[5] Accelerated coronary artery disease and risk factor profiles of patients undergoing percutaneous coronary intervention: A report from the American College of Cardiology National Cardiovascular Data Registry.
Shaw, RE
Naik, HS
Yee, RR
Hui, PYM
Gray, R
CIRCULATION, 2004, 109 (07) : E128 - E128
[6] TRANSRADIAL APPROACH IS ASSOCIATED WITH LOWER BLEEDING COMPLICATIONS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION WITH GLYCOPROTEIN IIB/IIIA INHIBITORS
Kerner, Arthur
Abergel, Eitan
Berger, Michael
Halabi, Majdi
Boulus, Monther
Beyar, Raphael
Roguin, Ariel
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
[7] Minimizing bleeding complications of percutaneous coronary intervention and glycoprotein IIb-IIIa antiplatelet therapy
Juran, NB
AMERICAN HEART JOURNAL, 1999, 138 (04) : S297 - S306
[8] Effect of glycoprotein IIb/IIIa receptor inhibition on angiographic complications during percutaneous coronary intervention in the ESPRIT trial
Blankenship, JC
Tasissa, G
O'Shea, JC
Iliadis, EA
Bachour, FA
Cohen, DJ
Lui, HK
Mann, T
Cohen, E
Tcheng, JE
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (03) : 653 - 658
[9] Cultivating Prognosis Following Percutaneous Coronary Intervention The American College of Cardiology/National Cardiovascular Data Registry Risk Score
Kereiakes, Dean J.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (18) : 1933 - 1935
[10] Assessment of the feasibility, safety, and success of transradial access for percutaneous coronary intervention: A report from the American College of Cardiology-National Cardiovascular Data Registry
Ahmed, AS
Murtaza, M
Catchings, T
Webel, R
Lin, B
Shaw, R
Flaker, GC
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 30A - 31A

← 1 2 3 4 5 →